MyAverix Finance
US · Healthcare
Gelesis Holdings Inc. (GLSHQ)
Biotechnology
Gelesis Holdings Inc. (GLSHQ) is listed on US in the Healthcare sector. Industry: Biotechnology. As of 2026-03-24, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for GLSHQ
Gelesis Holdings Inc. (GLSHQ) — FAQ
What is GLSHQ's P/E ratio?
The price-to-earnings (P/E) ratio for Gelesis Holdings Inc. (GLSHQ) is 18.00 (data as of 2026-03-24).
Does Gelesis Holdings Inc. pay a dividend?
Dividend yield is not available in the current snapshot for Gelesis Holdings Inc. (GLSHQ). Check the MyAverix Finance app for the latest dividend data.
What sector is Gelesis Holdings Inc. in?
Gelesis Holdings Inc. (GLSHQ) is classified in the Healthcare sector (Biotechnology industry).
What exchange is GLSHQ listed on?
GLSHQ is listed on US.
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.